In normal cells and early stages of cancer progression, TGFβ acts as a tumour suppressor [106] with the ability to induce apoptosis [107,108,109] and inhibit cell cycle progression by triggering G1 cell cycle arrest [107,110]. Here, TGFB1 is linked to neoplasm.